Jun 14, 2022

Cordis Announces Successful First-in-Human Use of the Radianz Radial Peripheral System™

Read more

Jun 13, 2022

Cordis-X Makes Strategic Investment in Adient Medical, Developer of First Fully Absorbable IVC Filter

Signals continued investment in accelerated cardiovascular technology development

Read more

Jun 6, 2022

Coronary Angiography and PCI During Contrast Shortages

Presented by Dr. Darshan Doshi

Read more

May 26, 2022

Tribute to Cardiology Pioneer Dr. José Eduardo Sousa

Cordis Pays Tribute to Cardiology Pioneer Dr. José Eduardo Sousa

Read more

Apr 5, 2022

Cordis Makes Strategic Investment in E2

Cordis Makes Strategic Investment in E2, a developer of Next-Generation Thrombectomy Devices Move signals new chapter of innovation for Cordis

Read more

Mar 17, 2022

S.M.A.R.T. RADIANZ Vascular Stent System Approved for Transradial Use in the U.S.

The Radianz Radial Peripheral System(TM); signals Cordis’ renewed investment in innovation

Read more

Jan 5, 2022

Cordis names Christopher Scully to CFO Post

Cordis, a global interventional cardiovascular technology company, today announced that Christopher Scully has joined the organization as Chief Finan...

Read more

Dec 8, 2021

Cordis Names Muscari President Of The Americas

Matthew Muscari takes the helm of global marketing and American sales as Cordis pursues path of transformation and growth

Read more

Mar 12, 2021

Cardinal Health signs definitive agreement to sell its Cordis business to Hellman & Friedman

Cardinal Health (NYSE: CAH) today announced that it has signed a definitive agreement to sell its Cordis business to Hellman & Friedman (H&F) for approximately $1 billion...

Read more